As of June 27, 2023 all Drug Enforcement Administration (DEA)-registered practitioners need to attest to 8 hours of CME dedicated to Opioid Use Disorder and/or Substance Use Disorder. This is a one-time attestation for all new and renewal applications. Past trainings do count towards the 8-hour requirement. If you previously held an X-Wavier or are boarded certified in addiction medicine, no further education is required for the DEA. Read more about the New DEA training requirement here. 

If you are looking for information on the Illinois relicensure requirements, visit this page: Illinois Licensure Requirements from IDFPR.

Requirements are subject to change, and each professional is responsible for ensuring that they are meeting the requirements for their licensure.

---> Looking to know what credits you have received so far through Advocate Aurora Health? Follow these instructions on How to print a certificate or a transcript <---

Below is a list of current offerings from Advocate Health to help meet the DEA education requirements. New offerings will be added, so be sure to check back often.

Online, recorded options:

• Opioid Prescribing Procedure (1 hour): Opioid prescribing is still an issue across the country.  This course was developed by AAH to simplify guidelines to enable prescribing clinicians across AAH to closely monitor patients’ opioid use.
   
• Opioid Weaning Procedure (30 minutes): This course covers the AAH recommendations for weaning patients from opioids: which patients should be weaned, the risks of weaning, and the newest clinical evidence for weaning procedure.
   
• Drug Screening for Opioid Therapy (30 minutes): This course describes challenges in drug testing patients on opioid for chronic pain. We recommend specific tests, and discuss possible results and actions that may be taken based on those results. Advice for inconsistent drug screen results is also discussed.
   
• Buprenorphine For Opioid Use Disorder (1 hour): This course will review of the use of buprenorphine for the treatment of opioid use disorder and discuss the barriers, challenges, risks, and efficacy of buprenorphine treatment.  Although evidence from numerous studies has shown buprenorphine to be effective for the treatment of opioid use disorder, a majority of patients with opioid use disorder do not receive buprenorphine, or any other medical treatment.
   
• Emergency Department Buprenorphine Induction-EM (1 hour): This activity reviews the most recent opioid death statistics, includes patient with lived experiences videos, reviews induction of buprenorphine, the mechanism of buprenorphine and introduction of new containment xylazine. Dr. Coogan leads case scenarios to review common questions regarding buprenorphine.
   
• Opioid Use Disorder PCP Case Conference (1 hour) 15-20 minute didactic session followed by real cases with discussion led by Dr. Diana Bottari, Addiction and Pain Medicine Physician.

• The Science Behind Chronic Pain: Language Providers Can Use for Patient Education and Identification of Opioid Use (68 minutes).  This course will review the science behind chronic pain and pain modulation systems. It will also review pain catastrophizing, opioid induced hyperalgesia, and diagnostic criteria for opioid use disorder. In addition, it touches upon motivational interviewing and how it can be used in your clinic.
   
• Opioid Crisis - Where do we stand in 2023 (50 minutes).  This course provides the most up-to-date information regarding the appropriate indication for opioids.   The conference covers the basics of opioid pharmacology and selection, evidence-based guidelines for opioid management, and medical and interventional alternatives to opioids.
   
• Opioid Series - No Opioids? No Problem - EM | Advocate Health (1 hour) This course is designed to improve understanding and identification of opioid use disorder, utilizing resources within Advocate Health to aid in combating the opioid crisis, and describe safe opioid prescribing practices and monitoring.
   
• Opioid Series - Dependency Vs Opioid Use Disorder - EM | Advocate Health (1 hour) This course is designed to improve understanding and identification of opioid use disorder, utilizing resources within Advocate Health to aid in combating the opioid crisis, and describe safe opioid prescribing practices and monitoring.
   

• Opioid Series- Weaning- When to, When not to - EM | Advocate Health (1 hour) This course is designed to improve understanding and identification of opioid use disorder, utilizing resources within Advocate Health to aid in combating the opioid crisis, and describe safe opioid prescribing practices and monitoring.

•  Functional Neurologic Disorder - EM | Advocate Health (1 hour) This course is designed to improve understanding and identification of opioid use disorder, utilizing resources within Advocate Health to aid in combating the opioid crisis, and describe safe opioid prescribing practices and monitoring.

Here are other resources available outside of Advocate Health to help meet the DEA education requirements:

• AMA Ed Hub: Substance Use Disorders and Addiction Education to Meet New DEA Requirements
• American College of Physicians: Pain Management Series 
• New England Journal of Medicine: Pain Management and Opioids - NEJM Knowledge 
• Providers Clinical Support System (PCSS): Substance Use Disorder Core Curriculum 

The following materials can be accessed with an aah.org email:

• ED Mat Algorithm: AAH Opioid Resources - AAH MAT Algorithm Rev 2023.03.23.pdf - All Documents (sharepoint.com)
• Pocket Guide for MAT: AAH Opioid Resources - Medication_Assistant_PocketGuide_Final.pdf - All Documents (sharepoint.com)
• Home Induction: 
  • AAH Opioid Resources - Home Inductions Pt Instructions 4mg rev.pdf - All Documents (sharepoint.com)
  • AAH Opioid Resources - Home Inductions Pt Instructions 8mg.pdf - All Documents (sharepoint.com)
• Wean Team Referral: AAH Opioid Resources - Tip Sheet_Service To Population Health Pharmacy - Facilitated Opioid Weaning (1).pdf - All Documents (sharepoint.com)